Section 3d Efficacy

Subscribe & Share!!
The contents in this video are purely for academic purposes and should not be construed as legal advise. This video has been created to support understanding of patent agent aspirants for exam point of view.
Register here for Live classes: www.iiipf.com
Buy book here:
1. www.whitesmann... (Publisher’s direct Page) or
2. www.amazon.in/...
What is in the Book?
• A Book on Master Guide...
WhatsApp here for any query: 9599305292

[@shifalysharma]

Informative

[@shifalysharma]

Q1 yes because efficacy in enhanced
Q2 no ( thermal stability may not make it ) otherwise efficacy seems to be enhanced ( doubtful)
Q3 no , as it’s just a new form.

[@dnarkam]

As per Novartis AG vs Union of India 2013, physico-chemical properties of a chemical compound,
namely (i) more beneficial flow properties, (ii) better thermodynamic stability, and (iii)
lower hygroscopicity, may be otherwise beneficial but these properties cannot even be
taken into account for the purpose of the test of section 3(d) of the Act, since these
properties have nothing to do with therapeutic efficacy.

[@sushmasanasam7687]

Ans for Quiz 2 and Quiz 3 is Not patentable.
Ans of Quiz 1 : Not patentable (Bit confused)

[@KnowledgeZoneK]

All 3 not patentable